115 related articles for article (PubMed ID: 27802193)
1. Preoperative multiplication of neutrophil and monocyte counts as a prognostic factor in epithelial ovarian cancer.
Paik ES; Shim M; Choi HJ; Lee YY; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS
Cancer Biomark; 2016; 17(4):419-425. PubMed ID: 27802193
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
Miao Y; Yan Q; Li S; Li B; Feng Y
Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical utility between neutrophil count and neutrophil-lymphocyte ratio in patients with ovarian cancer: a single institutional experience and a literature review.
Komura N; Mabuchi S; Yokoi E; Kozasa K; Kuroda H; Sasano T; Matsumoto Y; Kimura T
Int J Clin Oncol; 2018 Feb; 23(1):104-113. PubMed ID: 28951992
[TBL] [Abstract][Full Text] [Related]
4. Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer.
Paik ES; Sohn I; Baek SY; Shim M; Choi HJ; Kim TJ; Choi CH; Lee JW; Kim BG; Lee YY; Bae DS
Cancer Res Treat; 2017 Jul; 49(3):635-642. PubMed ID: 27669704
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with epithelial ovarian cancer.
Yildiz Y; Kucukzeybek Y; Alacacioglu A; Varol U; Yildiz I; Akyol M; Kabadayι G; Taskaynatan H; Salman T; Bayoglu V; Oflazoglu U; Tarhan MO
Eur J Gynaecol Oncol; 2017; 38(3):444-448. PubMed ID: 29693888
[TBL] [Abstract][Full Text] [Related]
6. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
Yang Z; Gu JH; Guo CS; Li XH; Yang WC
Oncotarget; 2017 Jul; 8(28):46414-46424. PubMed ID: 28423365
[TBL] [Abstract][Full Text] [Related]
7. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
Yang HM; Lou G
Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896
[No Abstract] [Full Text] [Related]
8. Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis.
Luo Y; Kim HS; Kim M; Lee M; Song YS
J Gynecol Oncol; 2017 May; 28(3):e36. PubMed ID: 28382799
[TBL] [Abstract][Full Text] [Related]
9. Preoperative red cell distribution width and neutrophil-to-lymphocyte ratio predict survival in patients with epithelial ovarian cancer.
Li Z; Hong N; Robertson M; Wang C; Jiang G
Sci Rep; 2017 Feb; 7():43001. PubMed ID: 28223716
[TBL] [Abstract][Full Text] [Related]
10. Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer.
Thavaramara T; Phaloprakarn C; Tangjitgamol S; Manusirivithaya S
J Med Assoc Thai; 2011 Jul; 94(7):871-7. PubMed ID: 21774296
[TBL] [Abstract][Full Text] [Related]
11. Can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? - a survival analysis.
Ceran MU; Tasdemir U; Colak E; Güngör T
J Ovarian Res; 2019 Feb; 12(1):16. PubMed ID: 30744662
[TBL] [Abstract][Full Text] [Related]
12. Pre-treatment diagnosis of endometrial cancer through a combination of CA125 and multiplication of neutrophil and monocyte.
Kim BW; Jeon YE; Cho H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
J Obstet Gynaecol Res; 2012 Jan; 38(1):48-56. PubMed ID: 22142582
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-to-Lymphocyte Ratio and Platelet Count Predict Long-Term Outcome of Stage IIIC Epithelial Ovarian Cancer.
Zhou M; Li L; Wang X; Wang C; Wang D
Cell Physiol Biochem; 2018; 46(1):178-186. PubMed ID: 29587273
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer.
Temur I; Kucukgoz Gulec U; Paydas S; Guzel AB; Sucu M; Vardar MA
Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():25-29. PubMed ID: 29804024
[TBL] [Abstract][Full Text] [Related]
15. Possible surrogate marker for an effective dose-dense chemotherapy in treating ovarian cancer.
Huang CY; Yang YC; Wang KL; Chen TC; Chen JR; Weng CS; Chien HJ; Chang CL
Taiwan J Obstet Gynecol; 2016 Jun; 55(3):405-9. PubMed ID: 27343324
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of preoperative leukocytosis in epithelial ovarian carcinoma: a retrospective cohort study.
So KA; Hong JH; Jin HM; Kim JW; Song JY; Lee JK; Lee NW
Gynecol Oncol; 2014 Mar; 132(3):551-5. PubMed ID: 24440470
[TBL] [Abstract][Full Text] [Related]
17. Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumour marker for cervical cancer.
Cho H; Kim JH
Biomarkers; 2009 May; 14(3):161-70. PubMed ID: 19399661
[TBL] [Abstract][Full Text] [Related]
18. The preoperative albumin level is an independent prognostic factor for optimally debulked epithelial ovarian cancer.
Ayhan A; Günakan E; Alyazıcı İ; Haberal N; Altundağ Ö; Dursun P
Arch Gynecol Obstet; 2017 Nov; 296(5):989-995. PubMed ID: 28875365
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.
Arakawa N; Kobayashi H; Yonemoto N; Masuishi Y; Ino Y; Shigetomi H; Furukawa N; Ohtake N; Miyagi Y; Hirahara F; Hirano H; Miyagi E
PLoS One; 2016; 11(10):e0165609. PubMed ID: 27798689
[TBL] [Abstract][Full Text] [Related]
20. Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer.
Qiu J; Yu Y; Fu Y; Ye F; Xie X; Lu W
J Obstet Gynaecol Res; 2012 Apr; 38(4):651-7. PubMed ID: 22413879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
